Tag: drug

Posted on

Theravance Falls Most in 3 Years After Glaxo Drug Fails – BusinessWeek


Visit Bulgaria

Theravance Falls Most in 3 Years After Glaxo Drug Fails
BusinessWeek
The company, based in South San Francisco, California, said in a statement today that Relovair, its drug for asthma and chronic obstructive pulmonary disease, proved no better than Glaxo's Seretide in a clinical trial. Relovair is “the most important …
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies …MarketWatch (press release)
Glaxo on the slide after trials setback for asthma drugEvening Standard
Theravance Shares Slide on Lung Drug DeathsTheStreet.com
Visit Bulgaria –Wall Street Journal (India) –FierceBiotech
all 73 news articles »

View full post on asthma – Google News

Posted on

Glaxo on the slide after trials setback for asthma drug – Evening Standard


Reuters UK

Glaxo on the slide after trials setback for asthma drug
Evening Standard
But clinical trials have not shown the new treatment to be better than GSK's flagship asthma drug Advair. "The results aren't a home run but look adequate for filing and approval," said pharma analyst Emmanuel Papadakis at Collins Stewart. …
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies …MarketWatch (press release)
GSK to seek approval of Theravance lung drugSan Francisco Business Times (blog)
For COPD, Glaxo intends to submit regulatory applications in the US and Europe …ShareCast
Reuters UK –Healthcare Global
all 37 news articles »

View full post on asthma – Google News

Posted on

GSK to seek approval of Theravance lung drug – San Francisco Business Times (blog)

GSK to seek approval of Theravance lung drug
San Francisco Business Times (blog)
GlaxoSmithKline will seek approval of the COPD drug Relovair in the United States and Europe in mid-year, and it and partner Theravance Inc. will continue to talk to regulators about also using the drug for asthma patients. …
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies …MarketWatch (press release)
Glaxo set to submit Relovair to regulatory authoritiesShareCast
GSK aims to file new lung drug Relovair in mid-2012Reuters UK
Capital.gr (press release)
all 12 news articles »

View full post on asthma – Google News

Posted on

Asthma sufferer hails new ‘life in a box’ drug – Buxton Advertiser


Buxton Advertiser

Asthma sufferer hails new ‘life in a box’ drug
Buxton Advertiser
By Jonathan Dodds A BUXTON mother suffering from severe asthma is looking to the New Year with renewed hope thanks to a new wonder drug which she has hailed as “life in a box”. Rebecca Hodkinson has suffered from persistent allergic asthma from an …

and more »

View full post on asthma – Google News

Posted on

Dudley Hill woman tries new drug for asthma sufferers – Bradford Telegraph and Argus

Dudley Hill woman tries new drug for asthma sufferers
Bradford Telegraph and Argus
By Claire Lomax » Patients with severe allergic asthma in Bradford are spending less time in hospital after testing a new drug to control their life-threatening condition. Bradford Teaching Hospitals NHS Foundation Trust is one of several centres …

and more »

View full post on asthma – Google News

Posted on

AstraZeneca takes option on Prosidion diabetes assets; advances asthma drug – The Pharma Letter


Financial Times

AstraZeneca takes option on Prosidion diabetes assets; advances asthma drug
The Pharma Letter
Separately, Dynavax Technologies (Nasdaq: DVAX) and AstraZeneca yesterday announced their decision to advance AZD1419, a proprietary second-generation TLR-9 agonist for asthma, into Investigational New Drug-enabling preclinical toxicology studies. …
The Market Just Spanked My Stock!Motley Fool

all 144 news articles »

View full post on asthma – Google News

Posted on

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion … – BioMedReports (subscription)

Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …
BioMedReports (subscription)
The overall asthma drug market will decrease slightly from $14.6 billion in 2010 to $14.4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. “Driving these sales will be the uptake of emerging once-daily …
Through 2020, the Asthma Drug Market Will Remain Flat Amidst Generic Erosion …MarketWatch (press release)

all 17 news articles »

View full post on asthma – Google News